AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 206 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caligan Partners LP | 514,711 | $22,194,338 | 5.19% |
| ACUTA CAPITAL PARTNERS, LLC | 78,700 | $3,393,544 | 2.86% |
| Bellevue Group AG | 3,879,548 | $167,286,110 | 2.72% |
| Parkman Healthcare Partners LLC | 446,416 | $19,249,458 | 2.58% |
| Eagle Health Investments LP | 330,830 | $14,265,390 | 2.50% |
| SECTOR GAMMA AS | 121,844 | $5,253,913 | 1.96% |
| Frazier Life Sciences Management, L.P. | 871,974 | $37,599,519 | 1.76% |
| BVF INC/IL | 1,190,107 | $51,317,414 | 1.44% |
| Rock Springs Capital Management LP | 1,044,261 | $45,028,534 | 1.36% |
| FARALLON CAPITAL MANAGEMENT LLC | 5,654,502 | $243,822,126 | 1.15% |
| ARMISTICE CAPITAL, LLC | 2,079,151 | $89,652,991 | 1.13% |
| CenterBook Partners LP | 249,311 | $10,750,290 | 0.67% |
| ArrowMark Colorado Holdings LLC | 1,019,357 | $43,954,674 | 0.52% |
| EAM Investors, LLC | 74,142 | $3,197,003 | 0.52% |
| PDT Partners, LLC | 75,280 | $3,246,074 | 0.31% |
| Granahan Investment Management | 136,838 | $5,900,455 | 0.24% |
| GW&K Investment Management, LLC | 595,066 | $25,659 | 0.23% |
| BOOTHBAY FUND MANAGEMENT, LLC | 223,979 | $9,657,974 | 0.23% |
| SEVEN EIGHT CAPITAL, LP | 39,262 | $1,692,977 | 0.18% |
| Pennant Investors, LP | 15,100 | $651,112 | 0.17% |
External links
This page lists AGIOS PHARMACEUTICALS INC's shareholders in Q2 2024. To view AGIOS PHARMACEUTICALS INC's shareholder history, click here.